Tag Archives: HHS

Your 2014 Medicaid Sales & Marketing Plans

By Guest Blogger | Published: May 21, 2013

by Tom Norton If you are an Rx regional sales director or a product marketing manager, I have a somewhat provocative question for you: How exactly are you planning your 2014 Medicaid strategy?

Posted in Advertising, Guest Blog, Legal, Market Access, Marketing, Regulatory, Sales, Strategy, healthcare, pricing | Also tagged ACA, CMS, Florida, Medicaid, Obamacare, Regulatory, sales and marketing, state health exchanges, States, Texas | Leave a comment

Congress 'Tip Toes' Around Obamacare

By Guest Blogger | Published: April 23, 2013

by Tom Norton Of the many issues involved with the actual implementation of the 2010 Affordable Care Act, aka, “Obamacare”, few are more intriguing to me than those that personally impact Members of Congress (MOCs). Here’s a good example of what I’m talking about — Today, on Capitol Hill, MOCs, along with thousands of their personal [...]

Posted in Guest Blog, Legal, Strategy, healthcare | Also tagged Affordable Care Act, Congress, healthcare, Obamacare, Politics, POTUS, Sen. Charles Grassley (R-IA), state health exchanges | 3 Comments

Are US and Canadian Rx Policies Converging?

By Guest Blogger | Published: March 19, 2013

by Tom Norton As the US pharmaceutical industry anxiously watches the rapid onset of Obamacare, certainly one of the more pressing issues is the debate over the number of drugs that will be reimbursed in each therapeutic class under the Essential Health Benefits (EHB) program. To say that this is a critical concern for the future [...]

Posted in Global, Guest Blog, Legal, Market Access, Strategy, healthcare | Also tagged Affordable Care Act, Canada, essential health benefits, health insurance, Medicare, Obamacare | Leave a comment

Patients on the Picket Line

By Ben Comer | Published: February 5, 2013

Good science can’t be rushed, even when the lives of patients hang in the balance. But regulatory science, and its relationship to a drug’s commercial success or failure, can inadvertently block access to individual patients in their hour of need.

Posted in Biotech, FDA, Legal, Market Access, Regulatory, Safety, healthcare | Also tagged Abigail Alliance, breakthrough therapies, Breast cancer, Cancer, compassionate use, Expanded Access Programs, FDA, FDA safety and innovation act, Market Access, patient advocates, PDUFA V, policy | Leave a comment

State Surprises as Obamacare Starts Up

By Guest Blogger | Published: February 1, 2013

by Tom Norton This past week or so, with Obamacare’s start up less than a year away, we have been treated to several entertaining vignettes as the nation’s governors begin to wrestle with the realities of the new healthcare law.

Posted in Guest Blog, Legal, Strategy, healthcare, leadership | Also tagged ACA, health exchanges, Health Reform, Kathleen Sebelius, Medicaid, Medicare, Obamacare, States | Leave a comment